News | November 13, 2023
Vaishali Pharma posts Q2 FY24 PAT at Rs. 1.70 Cr
he company posted total income during Q2 FY24 at Rs. 12.86 crore
he company posted total income during Q2 FY24 at Rs. 12.86 crore
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
PhytoSquene now available for clinical and commercial use
Lack of technology transfer stands out as a formidable barrier
The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian Industry (CII)
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Subscribe To Our Newsletter & Stay Updated
